Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  167,861 results for ""Rifampin""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effect of Itraconazole, a CYP3A4 Inhibitor, and Rifampin, a CYP3A4 Inducer, on the Pharmacokinetics of Vatiquinone.

  • Authors : Lee L; PTC Therapeutics, Inc., Warren, NJ, USA.; Thoolen M

Subjects: Itraconazole*/Itraconazole*/Itraconazole*/pharmacology ; Itraconazole*/Itraconazole*/Itraconazole*/administration & dosage ; Itraconazole*/Itraconazole*/Itraconazole*/pharmacokinetics

  • Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Dec; Vol. 13 (12), pp. 1283-1290. Date of Electronic Publication: 2024 Aug 12.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Rifampin-resistant periprosthetic joint infections are associated with worse functional outcome in both acute and chronic infection types.

  • Authors : Baumgärtner T; 1Department of Orthopaedic and Trauma Surgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany. Electronic address: .; Bdeir M

Subjects: Rifampin*/Rifampin*/Rifampin*/therapeutic use ; Rifampin*/Rifampin*/Rifampin*/pharmacology ; Prosthesis-Related Infections*/Prosthesis-Related Infections*/Prosthesis-Related Infections*/drug therapy

  • Source: Diagnostic microbiology and infectious disease [Diagn Microbiol Infect Dis] 2024 Oct; Vol. 110 (2), pp. 116447. Date of Electronic Publication: 2024 Jul 19.Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8305899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Deconvoluting zavegepant drug-drug interactions: A phase I study to evaluate the effects of rifampin and itraconazole on zavegepant pharmacokinetics.

Subjects: Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/pharmacology ; Rifampin*/Rifampin*/Rifampin*/pharmacokinetics

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Dec; Vol. 17 (12), pp. e70048.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Genomic analysis of two penicillin- and rifampin-resistant Corynebacterium rouxii strains isolated from cutaneous infections in dogs.

  • Authors : Araújo MRB; Operational Technical Nucleus, Microbiology, Hermes Pardini Institute (Fleury Group), Av. das Nações, 2448, Santo Antônio, 33200-000 Vespasiano, MG, Brazil.; Prates FD

Subjects: Corynebacterium*/Corynebacterium*/Corynebacterium*/genetics ; Corynebacterium*/Corynebacterium*/Corynebacterium*/drug effects ; Dog Diseases*/Dog Diseases*/Dog Diseases*/microbiology

  • Source: Research in veterinary science [Res Vet Sci] 2024 Nov; Vol. 179, pp. 105396. Date of Electronic Publication: 2024 Aug 26.Publisher: British Veterinary Association Country of Publication: England NLM ID: 0401300 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Distribution of lineages and type II toxin-antitoxin systems among rifampin-resistant Mycobacterium Tuberculosis Isolates.

  • Authors : Shafipour M; Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran.; Mohammadzadeh A

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects ; Toxin-Antitoxin Systems*/Toxin-Antitoxin Systems*/Toxin-Antitoxin Systems*/genetics

  • Source: PloS one [PLoS One] 2024 Oct 24; Vol. 19 (10), pp. e0309292. Date of Electronic Publication: 2024 Oct 24 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Infection by a multidrug-resistant Corynebacterium diphtheriae strain: prediction of virulence factors, CRISPR-Cas system analysis, and structural implications of mutations conferring rifampin resistance.

  • Authors : Araújo MRB; Operational Technical Nucleus, Microbiology, Hermes Pardini Institute, Vespasiano, Minas Gerais, Brazil.; Department of Genetics, Ecology and Evolution, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.

Subjects: Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/genetics ; Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/pathogenicity ; Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/Corynebacterium diphtheriae*/drug effects

  • Source: Functional & integrative genomics [Funct Integr Genomics] 2024 Aug 28; Vol. 24 (5), pp. 145. Date of Electronic Publication: 2024 Aug 28.Publisher: Springer Country of Publication: Germany NLM ID: 100939343 Publication Model: Electronic Cited Medium: Internet ISSN: 1438-7948

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R 2 randomized controlled trial.

  • Authors : Gafar F; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada; McGill International TB Centre, McGill University, Montreal, Quebec, Canada

Subjects: Rifampin*/Rifampin*/Rifampin*/pharmacokinetics ; Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/therapeutic use

  • Source: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Jul; Vol. 64 (1), pp. 107197. Date of Electronic Publication: 2024 May 14.Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Minocycline-rifampin-impregnated penile prosthesis surfaces retain antimicrobial activity following irrigation with 0.05% chlorhexidine gluconate and antibiotic solutions.

  • Authors : Im BH; Department of Urology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, United States.; Giordano A

Subjects: Chlorhexidine*/Chlorhexidine*/Chlorhexidine*/analogs & derivatives ; Chlorhexidine*/Chlorhexidine*/Chlorhexidine*/pharmacology ; Chlorhexidine*/Chlorhexidine*/Chlorhexidine*/administration & dosage

  • Source: The journal of sexual medicine [J Sex Med] 2024 Sep 03; Vol. 21 (9), pp. 823-826.Publisher: Oxford University Press Country of Publication: Netherlands NLM ID: 101230693 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Pharmacokinetics of olverembatinib (HQP1351) in the presence of a strong CYP3A4 inhibitor (itraconazole) or inducer (rifampin) in healthy volunteers.

  • Authors : Wang H; Guangzhou Healthquest Pharma Co., Ltd., Guangzhou, China.; Yang Y

Subjects: Itraconazole*/Itraconazole*/Itraconazole*/pharmacokinetics ; Itraconazole*/Itraconazole*/Itraconazole*/administration & dosage ; Itraconazole*/Itraconazole*/Itraconazole*/pharmacology

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Sep; Vol. 17 (9), pp. e70021.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dose-dependent induction of CYP3A activity by St. John's wort alone and in combination with rifampin.

  • Authors : Hohmann N; Department of Clinical Pharmacology and Pharmacoepidemiology, Internal Medicine IX, Medical Faculty of Heidelberg, Heidelberg University Hospital, University of Heidelberg, Heidelberg, Germany.; Friedrichs AS

Subjects: Rifampin*/Rifampin*/Rifampin*/administration & dosage ; Rifampin*/Rifampin*/Rifampin*/pharmacology ; Hypericum*/Hypericum*/Hypericum*/chemistry

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Aug; Vol. 17 (8), pp. e70007.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  167,861 results for ""Rifampin""